• Journal of Pharmaceutical Investigation
• /
• 제40권2호
• /
• pp.101-107
• /
• 2010

A rapid and sensitive reversed-phase high performance liquid chromatography (HPLC) method was developed for the determination of N-(-4-Chlorophenyl)-6-hydroxy-7-methoxy-2-chromanecarboxamide (KAL-1120), a novel anti-inflammation agent, in the rat plasma. The method was applied to analyze the compound in the biological fluids such as bile, urine and tissue homogenates. After liquid-liquid extraction, the compound was analyzed on an HPLC system with ultraviolet detection at 275 nm. HPLC was carried out using reversed-phase isocratic elution with a $C_{18}$ column, a mobile phase of a mixture of acetonitril (40 v/v%) at a flow rate of 1.0 mL/min. The chromatograms showed good resolution and sensitivity and no interference of plasma. The calibration curve for the drug in plasma was linear over the concentration range of 0.05-50 ${\mu}g$/mL. The intra- and inter-day assay accuracies of this method ranged from 0.06% to 9.33% of normal values and the precision did not exceed 6.28% of relative standard deviation. The plasma concentration of KAL-1120 decreased to below the quantifiable limit at 1.5 hr after the i.v. bolus administration of 2-10 mg/kg to rats ($t_{1/2,({\alpha})}$ and $t_{1/2,({\beta})$ of 2.15 and 26.7 min at a dose of 2 mg/kg, 3.91 and 33.0 min at a dose of 10 mg/kg, respectively). The steady-state volume of distribution ($V_{dss}$) and the total body clearance ($CL_t$) were not significantly altered in rats given doses from 2 to 10 mg/kg. Of the various tissues tested, KAL-1120 was mainly distributed in the lung and heart after i.v. bolus administration. KAL-1120 was detected in the bile by 30 min after its i.v. bolus administration. However, the concentration in the urine after i.v. bolus administration became too low to measure, suggesting that KAL-1120 is mostly excreted in the bile. In conclusion, this analytical method was suitable for the preclinical pharmacokinetic studies of KAL-1120 in rats.

• 한국초지조사료학회지
• /
• 제22권3호
• /
• pp.161-168
• /
• 2002

꽃사슴의 효율적인 사양관리를 위한 기초자료의 제시를 위해 근전도(EMG) Telemetry system을 이용한 사슴의 채식행동 조사가 실시되었다. 사슴은 다른 반추가축에 비해 빈번하고 불규칙한 채식행동 양식이 나타났다. 일중 채식과 반추에 소비한 시간은 각각 261분과 291분이었다. 사슴은 반추행동시에 일중 총 647회의 식괴와 1반추기당 평균 21.6회의 식괴를 토출했으며 1식괴당 26.9초의 반추시간을 나타냈다. 반추기간중 총 저작시간은 245.3분이었다. 총 저작수는 20,405회였으며 식괴당 31.5회, 분당 83.4회의 저작회수를 나타냈다. 시간대별 평균 식괴토출수는 09∼15시 사이에 15.3회로 가장 낮았고 15∼21시 사이에 26회로 가장 높았으며 이후 점차 저하되었다. 매 6시간 간격의 1식괴당 평균 저작회수는 시간이 경과함에 따라 증가되었다. 한편 섭취건물 100g당 채식시간과 반추시간은 각각 23.3분과 26.2분이었다. 결과적으로 사슴은 다소 불규칙하고 빈번한 채식과 반추 그리고 적은 식괴크기와 낮은 저작회수 등으로 인해 타 반추가축과는 다른 행동양식을 갖고 있기 때문에 이에 적합한 사양 관리가 필요할 것으로 판단된다.

• 한국산학기술학회논문지
• /
• 제13권5호
• /
• pp.2278-2284
• /
• 2012

파노라마방사선촬영 시 방사선감수성이 높은 갑상선의 방사선 피폭을 최소화하면서 진단에 유용한 영상을 얻기 위하여 조직등가물질인 보루스(bolus)를 차폐체로 사용하여 피폭선량 감소효과를 측정하였다. 실험은 2011. 6. 1일부터 6. 30일까지 두경부팬톰을 이용하여 갑상선 위치의 표면입사선량과 심부흡수선량을 측정하였다. 그 결과 갑상선 부위 입사표면선량은 평균 43.84 ${\mu}Gy$이었고, 10 mm 두께의 보루스로 만든 갑상선보호대에서는 평균 28.39 ${\mu}Gy$로 15.45 ${\mu}Gy$(35.24%)가 감소되었다. 20 mm 갑상선보호대를 착용했을 경우에는 평균 25.38 ${\mu}Gy$로 미착용 시 평균 43.84 ${\mu}Gy$보다 18.46 ${\mu}Gy$(42.10%)가 감소되었다. 그리고 표면에서 20 mm 깊이에서는 10 mm 두께의 갑상선보호대는 선량 감소효과가 없었고, 20 mm 갑상선보호대를 착용했을 경우에는 0.06 mSv (20%)의 선량감소효과가 있었다.

• 한국의학물리학회지:의학물리
• /
• 제25권4호
• /
• pp.225-232
• /
• 2014

본 논문에서는 자체 제작된 선량상승영역 변환기(build-up modifier, BM)을 투과하는 high energy photon beam의 심부선량백분율(PDD)을 특성을 측정하고 이 결과를 토대로 BM 산란인자(BM scatter factor, $S_{BM}$)를 계산하였다. 다양한 조건에서 BM scatter가 PDD의 Build-up region에 미치는 영향을 평가하고 BM의 유용성을 알아보는 것이 본 연구의 목적이다. $S_{BM}$는 BM을 사용하지 않은 SFS 30 mm에서 측정된 산란인자의 값을 1로서 정규화 하였다. 가장 큰 SFS 200 mm의 경우, 6 MV 광자선을 사용할 때 $S_{BM}$는 두께에 따라 각각 1.331, 1.519, 1.598, 1.641, 그리고 1.657이었다. 10 MV 광자선에는 각각 1.384, 1.662, 1.825, 1.913, 그리고 2.001이었다. BM의 효과는 bolus의 최대 76% 효율을 가지는 것으로 나타났다. Bolus를 밀착시키기 어려운 특정적 부위에 대해 BM은 그 대안으로써 효과적인 장치가 될 수 있을 것으로 기대된다.

• Radiation Oncology Journal
• /
• 제13권3호
• /
• pp.233-241
• /
• 1995

Purpose : To analyse clinical outcome and prognostic factors according to treatment modality, this paper report our experience of retrospective study of patients with esophageal cancer Materials and Methods : One hundred and ten patients with primary esophageal cancer who were treated in Presbyterian Medical Center from May 1985 to December 1992. We analysed these patients retrospectively with median follow up time of 28 months, one hundred and four patients($95{\%}$) were followed up from 15 to 69 months. In methods, twenty-eight patients were treated with median radiation dose irradiated 54.3Gy only. Fifty-six patients were treated with combined chemoradiotherapy. Sixteen cases of these patients were treated with concurrent chemoradiation and the other patients(forty cases) were treated sequential chemoradiotherapy. In concurrent chemoradiotherapy group, patients received 5-FU continuous IV infusion for 4 days. Cisplatin IV bolus. and concurrent esophageal irradiation to 30 Gy. After that patients received 5-FU continuous IV, Cisplatin bolus injection and Mitomycin-C bolus IV, Bleomycin continuous IV, and irradiation to 20 Gy. In sequential chemoradiotherapy group, the chemotherapy consisted of 5-FU 1,000mg/$m^2$ administered as a continuous 24 hour intravenous infusion during five days and Cisplatin 80-100mg/$m^2$ bolus injected, or Bleomycin, Vinblastine, Cisplatin, Methotrexate were used of 1 or 2 cycles. After preoperative concurrentm chemoradiation twenty-six patients underwent radical esophagectomy. Results : Ninety-three patients could be examined for response assessment, By treatment modality, response rates were $85.1{\%}$ for radiation alone group and $86.3{\%}$ for combined chemoradiation group. But in operation group, after one cycle of concurrent chemoradiation treatment, response rate was $61.9{\%}$. The pathologic complete response were $15.4{\%}$ in operation group. Overall median survival was II months and actuarial 5-year survival rate was $8{\%}$. The median survival interval was 6 months for radiation alone group, 11 months for combined chemoradiation group and 19 months for operation group. And also median survival was 19 months for complete responder group that 8 months for noncomplete responder group. In univariative analysis, statistically significant prognostic factors were tumor size, clinical stage, tumor response, and operation. In multivariative analysis, significantly better survival was associated with clinical stage, tumor response, radiation dose, and operation. Conclusion : Compared with radiotherapy alone, combined multimodality may improve the median survival in patients with localized carcinoma of the esophagus and toxicity is acceptable.

• 한국초지조사료학회지
• /
• 제33권4호
• /
• pp.290-297
• /
• 2013

본 연구는 버섯재배부산물, 재활용가금깔개, 미강 및 straw로 구성되는 BF 사일리지 급여가 육성 거세한우의 행동양상에 미치는 영향을 규명하기 위하여 실시하였다. 시험에 사용한 공시 한우는 11개월령 총 10두(평균 301.7 kg)를 2처리로 배치하였으며, 이 때 대조구(볏짚 자유채식)와 처리구(BF silage 자유채식)로 하여 48시간 행동관찰을 실시하였다. 대조구와 비교해서 BF 사일리지 급여구는 총 DM 섭취량과 NDF 섭취량이 각각 30% 및 36% 높았고, 채식시간, 반추시간 및 저작시간은 유의적인 차이가 없었다. 식괴수, 식괴당 반추시간에 있어서도 유의적 차이가 없었고, 식괴당 저작수와 FVI는 낮게 나타났다(p<0.05). 또한 대조구와 비교해서 BF 사일리지 급여구는 배뇨 회수가 높고(p<0.05), 음수 및 배분 회수에 있어서는 상호간에 차이가 없었고, 채식율, 반추효율 및 저작효율에 있어서는 더 높게 나타났다(p<0.05). 이상의 결과로 볼 때, BF 사일리지 급여는 볏짚과 비교 시 육성거세한우의 반추행동 상 큰 차이가 없다는 결과로 미루어 볼 때 차후 볏짚 대용으로 활용하여도 좋을 것으로 사료되었다. 즉 입자도가 큰 straw를 peNDF를 충족시키는 최소량을 혼합하여 부산물사료 사일리지를 제조, 급여하였을 때 육성거세한우의 반추행동은 볏짚 급여 시와 차이가 없었다.

• 한국초지조사료학회지
• /
• 제41권4호
• /
• pp.234-241
• /
• 2021

본 연구는 Holstein 거세 비육우의 성장 단계에 따른 채식 및 반추행동에 미치는 영향을 규명하기 위하여 실시하였다. 실험에 사용한 공시 Holstein 거세우는 육성 단계(T1), 비육전기 단계(T2) 그리고 비육 후기 단계(T3)을 각각 3두씩, 총 9두를 3처리 3반복으로 배치하였다. 사료급여는 농후사료 체중의 1.62%, 조사료는 자유 채식시킨 후 육안으로 48시간 채식 행동관찰을 실시하였다. 체중대비 건물섭취량은 T1구(2.21%) 가장 높게 T3구(1.39%)가 가장 낮게 나타났다. 채식시간은 T1, 반추시간은 T2 그리고 휴식시간은 T3 구에서 높게 나타났다(p<0.05, 0.01). 저작 시간은 T1 및 T2구에 비하여 T3구가 현저히 떨어지는 것으로 나타났다(p<0.01). 식괴수와 총 저작수는 다른 처리구에 비하여 T2구가 유의적으로 높게 나타났다(p<0.01). 그러나 식괴 당 저작수 및 분 당 식괴수는 T1구가 높게 나타났지만 상호 처리간 유의적인 수준은 나타나지 않았다. 음수 회수 및 배분 회수는 처리구들 간에 유의적인 차이가 없었다. 그러나 배뇨 회수는 어린 단계인 T1 구에서 유의적으로 높게 나타났다(p<0.01). 음수 시간, 배분시간, 배뇨시간은 T1 구에서 높게 나타났지만, 개체 차이가 심하여 유의적인 차이는 보이지 않았다. 이상의 결과를 종합하면 비육후기 단계(T3)는 육성(T1) 및 비육전기(T2)비하여 체중대비 채식량이 낮음에 따라 채식시간 반추시간은 줄어들고 휴식시간은 증가하는 것으로 나타났다. 또한 T3구는 총 식괴수 및 총 저작수도 떨어지는 것으로 나타났다.

• Journal of Dental Anesthesia and Pain Medicine
• /
• 제24권1호
• /
• pp.19-35
• /
• 2024

Background: This study investigated a safe and effective bolus dose and lockout time for patient-controlled sedation (PCS) with dexmedetomidine for dental treatments. The depth of sedation, vital signs, and patient satisfaction were investigated to demonstrate safety. Methods: Thirty patients requiring dental scaling were enrolled and randomly divided into three groups based on bolus doses and lockout times: group 1 (low dose group, bolus dose 0.05 ㎍/kg, 1-minute lockout time), group 2 (middle dose group, 0.1 ㎍/kg, 1-minute), and group 3 (high dose group, 0.2 ㎍/kg, 3-minute) (n = 10 each). ECG, pulse, oxygen saturation, blood pressure, end-tidal CO₂, respiratory rate, and bispectral index scores (BIS) were measured and recorded. The study was conducted in two stages: the first involved sedation without dental treatment and the second included sedation with dental scaling. Patients were instructed to press the drug demand button every 10 s, and the process of falling asleep and waking up was repeated 1-5 times. In the second stage, during dental scaling, patients were instructed to press the drug demand button. Loss of responsiveness (LOR) was defined as failure to respond to auditory stimuli six times, determining sleep onset. Patient and dentist satisfaction were assessed before and after experimentation. Results: Thirty patients (22 males) participated in the study. Scaling was performed in 29 patients after excluding one who experienced dizziness during the first stage. The average number of drug administrations until first LOR was significantly lower in group 3 (2.8 times) than groups 1 and 2 (8.0 and 6.5 times, respectively). The time taken to reach the LOR showed no difference between groups. During the second stage, the average time required to reach the LOR during scaling was 583.4 seconds. The effect site concentrations (Ce) was significantly lower in group 1 than groups 2 and 3. In the participant survey on PCS, 8/10 in group 3 reported partial memory loss, whereas 17/20 in groups 1 and 2 recalled the procedure fully or partially. Conclusion: PCS with dexmedetomidine can provide a rapid onset of sedation, safe vital sign management, and minimal side effects, thus facilitating smooth dental sedation.

• 한국임상수의학회:학술대회논문집
• /
• 한국임상수의학회 2006년도 춘계학술대회
• /
• pp.136-136
• /
• 2006

• Preventive Nutrition and Food Science
• /
• 제10권1호
• /
• pp.40-45
• /
• 2005

Age-related changes in bone metabolism are well established by biochemical markers of bone matrix in serum and urine, but analysis of the residual bone matrix, which is still turning over, has not been investigated. In the present study, we measured in vivo rates of bone protein synthesis using a precursor-product method based on the exchange of ²H from ²H₂O into amino acids. Four percent ²H₂O was administered to mice in drinking water after intraperitonial (i.p) bolus injection of 99.9% ²H₂O. Mice were divided into the two groups: growing young mice were administered 4% ²H₂O for 12 weeks after an i.p bolus injection at 5 week of age, whereas weight stable adult mice started drinking 4% ²H₂O 8 weeks later than the growing group and continued 4% ²H₂O drinking for 8 weeks. Mass isotopomer abundance in alanine from bone protein was analyzed by gas chromatography/mass spectrometry. Body ²H₂O enrichments were in the range of 1.88-2.41% over the labeling period. The fractional synthesis rates (ks) of bone protein were 2.000±0.071%/d for growing mice and 0.243±0.014%/d for adult mice. These results demonstrate that the bone protein synthesis rate decreases with age and present direct evidence of age-related changes in bone protein synthesis.